United Kingdom · Question · Written question
UIN 1767
Cystic Fibrosis: Drugs
Original
Introduced
13 November 2023
Last action
20 December 2023 · Answer
Status
Answered
Sponsors
—
Subjects
Discovery layer
Source updated
20 December 2023
Summary
To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 9 November 2023 to Question 346 on Cystic Fibrosis: Drugs, whether her Department plans to measure the long-term health outcomes of the cohort of people with cystic fibros
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
13 November 2023
Written question
To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 9 November 2023 to Question 346 on Cystic Fibrosis: Drugs, whether her Department plans to measure the long-term health outcomes of the cohort of people with cystic fibros
Source: Commons
20 December 2023
Answer
Long-term health outcomes of the cohort of people with cystic fibrosis who have been treated with Orkambi, Symkevi or Kaftrio through the National Health Service are collected by the UK Cystic Fibrosis Registry.Almost all people with cystic fibrosis in th...
Source: Written answer
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
No documents linked.
Sponsors
- · Department of Health and Social Care · Answering body
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://questions-statements.parliament.uk/written-questions/detail/2023-11-13/1767
- Open data entity: https://questions-statements-api.parliament.uk/api/writtenquestions/questions/1669745
- uk · wq-1669745 · source updated 20 December 2023